The U.S. elastomeric infusion pumps market includes various products such as variable rate elastomeric pumps and continuous rate elastomeric pumps which are used for the treatment of various indication such as oncology, post- operative care, general medicine, and others. The elastomeric infusion pumps are used to deliver the medication through intravenous route through IV line, the medication prescribed is filled in the chamber and the pressure is applied to the balloon for delivery of medication.

Market Dynamics

The increasing usage of antibiotics and other anti-infective drugs for the treatment of infectious diseases is expected to drive the segment growth over the forecast period

For instance, according to the Report of Centers for Disease Control and Prevention, in 2016, 270.2 million antibiotic prescriptions were written in the U.S.  Increasing application of elastomeric infusion pumps in outpatient parenteral antimicrobial therapy is expected to boost the growth of the market

The increasing incidence of chronic blood diseases such as blood cancers which include leukemia, lymphoma, and myeloma or blood disorder such as anemia, bleeding disorders such as blood clots and hemophilia is expected to drive the segment growth over the forecast period.

According to the Centers for Disease Control and Prevention (CDC) in 2019, the Sickle Cell Disease (SCD) affects around 100,000 Americans each year. Moreover, according to Leukemia & Lymphoma Society, it was estimated that around 172,910 people in the U.S. were expected to be diagnosed with the leukemia, lymphoma or myeloma in 2017.

 Key features of the study:

• This report provides in-depth analysis of the U.S. elastomeric infusion pumps market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2022–2028)
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, regional outlook, and competitive strategies adopted by the leading players.
• It profiles leading players in the U.S. elastomeric infusion pumps market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future market expansion, and marketing tactics
• The U.S. elastomeric infusion pumps market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
• Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the U.S. elastomeric infusion pumps market

 Detailed Segmentation:

• U.S. Elastomeric Infusion Pumps Market, By Product Type :
• Variable Rate Elastomeric Pumps
• Continuous Rate Elastomeric Pumps
• U.S. Elastomeric Infusion Pumps Market, By Indication :
• Oncology
• Post-operative Care
• General Medicine
• Others
• U.S. Elastomeric Infusion Pumps Market, By End User :
• Ambulatory Surgical Centers
• Clinics
• Home Care Settings
• Oncology
• Post-operative Care
• General Medicine
• Others
• Hospitals
• Others
• Company Profiles
• B. Braun Melsungen AG.*
• Company Overview
• Material Portfolio
• Financial Performance
• Key Highlights
• Market Strategies
• Baxter International Inc.
• Werfen
• Ambu A/S
• Avanos Medical Inc.
• Aeglea BioTherapeutics
• NIPRO
• Progressive Medical, Inc.

 “*” marked represents similar segmentation in other categories in the respective section.